Ardigen, ImmuMap and Pepscan kick-off collaboration for T-cell receptor discovery

Ardigen. ImmuMap and Pepscan recently kicked off their collaboration. The research study, called Creating an innovative AI-based (artificial intelligence) in silico technology TCRact to launch a new service for designing and optimizing T-cell receptors (TCR) for use in cancer immunotherapies, is partly funded through a grant obtained by Ardigen from the EU’s European Regional Development Fund under the Intelligent Development Program. 

Read further

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from - Youtube
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound